SUMO2 and hepatocellular carcinoma: Further, we found that patients with HCC having the high expression of SUMO2 and SAE1 showed significantly shorter OS time (Figure 1f–g), while no prognostic significance was observed for PIAS3 and CBX4 expression in the disease (Figure A1a and b).